Watch Now:Â Calidi Biotherapeutics and City of Hope announce first patients dosed in a Phase 1 clinical trial
→
Company
Company
About
History
Team
Careers
Medical &Â Scientific Advisors
Board of Advisors
Our Science
How It Works
Novel Platform
Publications
Medical &Â Scientific Advisors
Board of Advisors
Our Science
Pipeline
Newsroom
Investors
English
Contact
Publication
ASCO-SITC Clinical Immuno-Oncology Symposium February 6-8, 2020 Orlando, Florida.
Abstract 21: A cell-based platform to potentiate oncolytic virus therapies
February 6, 2020
A talented, seasoned group of world-class executives, doctors, and scientists producing revolutionary work.
Learn more
A talented, seasoned group of world-class executives, doctors, and scientists producing revolutionary work.
Learn more
